Last Updated:
10 Mar 2026, 03:29:55 PM (IST)
Sigachi Industries Limited
NSE: SIGACHI BSE: SIGACHI
NSE
19.46
0.69 (3.68%)
Prev Close
18.77
Open Price
19
Volume
2,548,412
Today Low / High
18.9 / 19.56
52 WK Low / High
18.25 / 59.59
Range
18 - 20
BSE
19.48
0.75 (4.00%)
Prev Close
18.73
Open Price
19.6
Volume
125,912
Today Low / High
18.93 / 19.6
52 WK Low / High
18.26 / 59.5
Range
19 - 20
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 19.46 (target range: 18 - 20), reflecting a change of 0.69 (3.67608%). On the BSE, it is listed at 19.48 (target range: 19 - 20), showing a change of 0.75 (4.00427%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Sigachi Industries Limited Graph
Sigachi Industries Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sigachi Industries Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 19.46, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 19.48 | 19.67 | 17.71 - 21.64 |
| 19.87 | 15.90 - 23.84 | ||
| 20.06 | 14.05 - 26.08 | ||
| Bearish Scenario | 19.48 | 19.29 | 17.36 - 21.21 |
| 19.09 | 15.27 - 22.91 | ||
| 18.90 | 13.23 - 24.56 |
Overview of Sigachi Industries Limited
ISIN
INE0D0K01022
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
5,656,533
Market Cap
7,573,559,138
Last Dividend
0.1
Official Website
IPO Date
2021-11-15
DCF Diff
109.81
DCF
-54
Financial Ratios Every Investor Needs
Stock Dividend of SIGACHI
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-09-16 | September 16, 25 | 0.1 | 0.1 | 2025-09-16 | 2025-10-20 | |
| 2024-08-28 | August 28, 24 | 0.1 | 0.1 | 2024-08-28 | 2024-10-04 | |
| 2023-08-31 | August 31, 23 | 0.1 | 1 | 2023-08-31 | 2023-09-20 | |
| 2022-08-02 | August 02, 22 | 0.1 | 1 | 2022-08-03 | 2022-08-21 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 488.24 Cr | 311.52 Cr | 176.72 Cr | 0.3619 | 0.00 Cr | 20.52 Cr | 84.21 Cr | 69.56 Cr | 2.06 | 120.51 Cr | 0.1425 |
| 2024-03-31 | 398.96 Cr | 226.24 Cr | 172.72 Cr | 0.4329 | 0.06 Cr | 15.79 Cr | 66.01 Cr | 57.18 Cr | 1.81 | 85.83 Cr | 0.1433 |
| 2023-03-31 | 302.05 Cr | 138.38 Cr | 163.67 Cr | 0.5419 | 0.51 Cr | 13.35 Cr | 52.91 Cr | 43.54 Cr | 1.42 | 65.40 Cr | 0.1441 |
| 2022-03-31 | 250.29 Cr | 138.45 Cr | 111.84 Cr | 0.4468 | 0.43 Cr | 3.26 Cr | 50.80 Cr | 40.04 Cr | 1.54 | 55.67 Cr | 0.1600 |
| 2021-03-31 | 192.76 Cr | 118.92 Cr | 73.84 Cr | 0.3831 | 0.32 Cr | 3.50 Cr | 73.96 Cr | 30.26 Cr | 1.31 | 42.04 Cr | 0.1570 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 17.26 Cr | 846.21 Cr | 233.13 Cr | 600.8496 Cr | 144.66 Cr | 127.40 Cr | 94.27 Cr | 323.08 Cr | 0.00 Cr | 0.00 Cr | 24.85 Cr | 185.1189 Cr |
| 2024-03-31 | 17.42 Cr | 694.16 Cr | 253.13 Cr | 429.6374 Cr | 151.07 Cr | 133.67 Cr | 70.72 Cr | 304.62 Cr | 0.01 Cr | 20.46 Cr | 14.74 Cr | 187.8233 Cr |
| 2023-03-31 | 13.75 Cr | 373.75 Cr | 105.39 Cr | 268.3606 Cr | 68.48 Cr | 53.85 Cr | 46.60 Cr | 156.53 Cr | 0.88 Cr | 2.50 Cr | 18.15 Cr | 74.6259 Cr |
| 2022-03-31 | 29.08 Cr | 286.80 Cr | 59.02 Cr | 227.7796 Cr | 34.90 Cr | 5.82 Cr | 30.45 Cr | 70.92 Cr | 0.38 Cr | 0.92 Cr | 32.06 Cr | 51.4435 Cr |
| 2021-03-31 | 15.90 Cr | 133.41 Cr | 39.21 Cr | 94.1994 Cr | 20.93 Cr | 5.03 Cr | 21.20 Cr | 41.37 Cr | 0.51 Cr | 0.00 Cr | 0.15 Cr | 32.1793 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.0323 Cr | -97.5840 Cr | 93.5147 Cr | -24.2980 Cr | 54.6034 Cr | 72.0199 Cr | -102.4890 Cr | 69.5631 Cr | -8.7630 Cr | -3.2819 Cr | -23.5483 Cr |
| 2024-03-31 | 12.8916 Cr | -160.7441 Cr | 172.1034 Cr | -72.2966 Cr | 24.2509 Cr | 57.0568 Cr | -85.1882 Cr | 57.1802 Cr | 79.5896 Cr | -3.0743 Cr | -3.8771 Cr |
| 2023-03-31 | 29.0167 Cr | -91.8522 Cr | 26.2081 Cr | -71.6990 Cr | -36.6273 Cr | 32.7554 Cr | -100.7157 Cr | 54.4788 Cr | 6.4658 Cr | -3.0743 Cr | -16.1554 Cr |
| 2022-03-31 | 5.8501 Cr | -62.8577 Cr | 108.3740 Cr | -18.4803 Cr | 51.3663 Cr | 69.3827 Cr | -24.3303 Cr | 51.5987 Cr | 14.1383 Cr | -2.3048 Cr | -9.2496 Cr |
| 2021-03-31 | 29.5511 Cr | -11.4323 Cr | -10.6922 Cr | 20.2672 Cr | 7.4266 Cr | 18.0164 Cr | -9.2839 Cr | 38.4837 Cr | -8.7483 Cr | -0.7682 Cr | 6.7263 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 117.21 Cr | 93.10 Cr | 24.10 Cr | 0.2057 | 1.53 Cr | 0.20 Cr | 0.01 | 5.71 Cr | 0.0017 |
| 2025-09-30 | 110.48 Cr | 86.26 Cr | 24.22 Cr | 0.2192 | 3.42 Cr | 10.69 Cr | 0.28 | 14.67 Cr | 0.0968 |
| 2025-06-30 | 128.25 Cr | 62.80 Cr | 65.45 Cr | 0.5103 | 19.38 Cr | -100.35 Cr | -2.63 | -92.96 Cr | -0.7825 |
| 2025-03-31 | 128.20 Cr | 76.32 Cr | 51.89 Cr | 0.4047 | 23.81 Cr | 13.27 Cr | 0.40 | 30.75 Cr | 0.1035 |
| 2024-12-31 | 139.42 Cr | 64.75 Cr | 74.67 Cr | 0.5356 | 28.51 Cr | 21.35 Cr | 0.65 | 35.19 Cr | 0.1532 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 21.34 Cr | 60.44 Cr | 81.77 Cr | 189.46 Cr | 107.83 Cr | 471.79 Cr | 286.50 Cr | 850.74 Cr | 331.53 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 72.02 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -613.08 Cr |
| 2025-03-31 | 72.02 Cr | 0.00 Cr | 72.02 Cr | 183.67 Cr | 94.27 Cr | 394.33 Cr | 323.08 Cr | 846.21 Cr | 233.13 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 48.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -481.98 Cr |
| 2024-09-30 | 8.18 Cr | 68.37 Cr | 76.55 Cr | 172.31 Cr | 91.12 Cr | 361.62 Cr | 312.62 Cr | 752.75 Cr | 270.78 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -100.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 13.27 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 21.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 21.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 13.16 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-10-09 | October 09, 23 | 10:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
CEO, MD & Director
Amit Raj Sinha
Gender: male
Year Born: 1973
VP & Business Head
Bobby Agrawal
Gender: male
Year Born: 1970
Director of Sigachi U.S. Inc
C. Bhavani Shanmugam
Gender: male
Year Born:
Executive Vice Chairman
Chidambarnathan Shanmuganathan
Gender: male
Year Born: 1943
Executive Chairman
Rabindra Prasad Sinha
Gender: male
Year Born: 1950
Vice President Operations
Radhakrishna Dattatraya Gadakh
Gender: male
Year Born:
Chief Financial Officer
Subbarami Reddy Oruganti
Gender: male
Year Born: 1974
Senior Vice President of HR
Subramanian Ananthanarayanan
Gender: male
Year Born: 1970
Company Secretary & Compliance Officer
Vivek Kumar
Gender: male
Year Born:
Deputy Group Chief Executive Officer
Lijo Stephen Chacko
Gender: male
Year Born: 1973
FAQs about Sigachi Industries Limited
Who is the CEO of the company?
The CEO is Amit Raj Sinha.
What is the current market price of the stock?
The current price is ₹19.82.
What is the 52-week price range?
The range is ₹18.92-59.59.
What is the market capitalization of the company?
The market capitalization is ₹757.36 crores.
What is the dividend yield?
The dividend yield is 0.50%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -9.94.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Sigachi Industries Limited (ISIN: INE0D0K01022) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹757.36 crores and an average daily volume of 5,656,533 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.1.